DR THORNILEY-WALKER & PARTNERS
GIBSON COURT, BOLDON COLLIERY
CHD 14
The percentage of patients with a history of myocardial infarction (from 1 April 2011) currently treated with an ACE inhibitor (or ARB if ACE intolerant), aspirin or an alternative anti-platelet therapy, beta blocker and statin (unless a contraindication or side effects are recorded)
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| CHD 11 | 2005 | 11 | 12 | 91.7% | |
| CHD 11 | 2006 | 12 | 13 | 92.3% | |
| CHD 11 | 2007 | 23 | 25 | 92.0% | |
| CHD 11 | 2008 | 23 | 23 | 100.0% | |
| CHD 11 | 2009 | 30 | 32 | 93.8% | |
| CHD 11 | 2010 | 31 | 33 | 93.9% | |
| CHD 11 | 2011 | 34 | 37 | 91.9% | |
| CHD 14 | 2012 | 14 | 14 | 100.0% | |
| CHD 14 | 2013 | 24 | 26 | 92.3% | |
| CHD006 | 2014 | 23 | 23 | 100.0% | |
| CHD006 | 2015 | 25 | 25 | 100.0% |
